Apex Biotechnology Corp (1733) — Financial Flexibility Index
Apex Biotechnology Corp (1733) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of NT$8.16 Million (operating CF NT$5.19 Million minus capex NT$2.97 Million) represents 0% of total liabilities (NT$494.69 Million). Check Apex Biotechnology Corp (1733) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Apex Biotechnology Corp Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Apex Biotechnology Corp across 23 annual periods. For the full cash flow conversion analysis, see Apex Biotechnology Corp cash flow conversion.
Annual Financial Flexibility Index for Apex Biotechnology Corp (2002–2024)
Year-by-year free cash flow to debt coverage for Apex Biotechnology Corp. Explore cash flow to debt ratio of Apex Biotechnology Corp to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.60x | NT$358.30 Million | NT$328.67 Million | NT$595.70 Million | ▲ +17.8% |
| 2023 | 0.51x | NT$255.37 Million | NT$230.39 Million | NT$500.07 Million | ▲ +432.6% |
| 2022 | 0.10x | NT$66.82 Million | NT$26.62 Million | NT$696.81 Million | ▼ -57.3% |
| 2021 | 0.22x | NT$206.07 Million | NT$179.87 Million | NT$916.91 Million | ▼ -31.3% |
| 2020 | 0.33x | NT$328.93 Million | NT$280.60 Million | NT$1.01 Billion | ▼ -28.3% |
| 2019 | 0.46x | NT$519.11 Million | NT$462.52 Million | NT$1.14 Billion | ▲ +188.1% |
| 2018 | 0.16x | NT$142.85 Million | NT$67.57 Million | NT$901.70 Million | ▲ +68.0% |
| 2017 | 0.09x | NT$97.59 Million | NT$70.83 Million | NT$1.03 Billion | ▼ -78.5% |
| 2016 | 0.44x | NT$336.51 Million | NT$298.06 Million | NT$768.49 Million | ▼ -32.9% |
| 2015 | 0.65x | NT$498.81 Million | NT$472.15 Million | NT$764.69 Million | ▲ +52.5% |
| 2014 | 0.43x | NT$333.02 Million | NT$267.60 Million | NT$778.52 Million | ▼ -53.1% |
| 2013 | 0.91x | NT$732.45 Million | NT$484.77 Million | NT$803.47 Million | ▼ -27.5% |
| 2012 | 1.26x | NT$924.37 Million | NT$509.67 Million | NT$735.18 Million | ▲ +40.4% |
| 2011 | 0.90x | NT$348.08 Million | NT$273.45 Million | NT$388.76 Million | ▼ -54.2% |
| 2010 | 1.95x | NT$626.64 Million | NT$465.59 Million | NT$320.60 Million | ▲ +27.6% |
| 2009 | 1.53x | NT$464.62 Million | NT$391.29 Million | NT$303.31 Million | ▼ -21.1% |
| 2008 | 1.94x | NT$429.70 Million | NT$299.96 Million | NT$221.21 Million | ▼ -5.1% |
| 2007 | 2.05x | NT$419.34 Million | NT$364.62 Million | NT$204.80 Million | ▼ -1.2% |
| 2006 | 2.07x | NT$405.70 Million | NT$363.71 Million | NT$195.73 Million | ▲ +57.8% |
| 2005 | 1.31x | NT$293.44 Million | NT$212.14 Million | NT$223.36 Million | ▼ -64.0% |
| 2004 | 3.65x | NT$469.70 Million | NT$218.54 Million | NT$128.64 Million | ▲ +24.3% |
| 2003 | 2.94x | NT$358.46 Million | NT$302.25 Million | NT$122.00 Million | ▲ +86.4% |
| 2002 | 1.58x | NT$140.62 Million | NT$79.49 Million | NT$89.21 Million | — |